|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.300 USD | -3.77% |
|
-2.54% | +50.33% |
| 06-15 | Compugen Ltd. - Special Call | |
| 06-11 | Compugen Presents Trial-In-Progress Poster On MAIA-Ovarian Phase 1 Study Of COM701 At ESMO Gynaecological Cancers Congress 2026 | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Other Biotechnology & Medical Research
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 226M | - | - | - | ||
| 50.73B | |||||
| 39.73B | - | - | - | - | - |
| 34.69B | |||||
| 33.21B | |||||
| 26.76B |
- Stock Market
- Stocks
- CGEN Stock
- Charts Compugen Ltd.
- Sector Chart
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
